Current oncology最新文献

{"title":"A Rare Case of Descending Colon Metastasis Following Radical Nephroureterectomy for Left Ureteral Carcinoma: A Case Report and Literature Review.","authors":"Huaiwen Zhang, Heyang Liu, Yousong Luo, Peizhe Li, Lianjun Yang, Jing Shi, Junyao Duan, Yongji Yan","doi":"10.3390/curroncol33040235","DOIUrl":"https://doi.org/10.3390/curroncol33040235","url":null,"abstract":"<p><p>Upper tract urothelial carcinoma (UTUC) is a rare and aggressive malignancy, accounting for only 5-10% of all urothelial carcinomas (UCs). Lung, bone, liver, and distant lymph nodes are common sites of metastasis, while gastrointestinal metastasis is extremely rare. We present a case of a 63-year-old female who developed a descending colon lesion 19 months after left radical nephroureterectomy for high-grade ureteral UC. The diagnosis was established by computed tomography (CT), magnetic resonance imaging (MRI), colonoscopy, and biopsy, which excluded primary colorectal malignancy. First-line therapy consisted of six 21-day cycles of gemcitabine plus cisplatin, followed by two cycles of tislelizumab maintenance immunotherapy. Restaging with contrast-enhanced CT and positron emission tomography/computed tomography (PET/CT) demonstrated disease progression. Despite switching to second-line nab-paclitaxel, the patient rapidly deteriorated from tumor cachexia and ultimately succumbed to septic shock secondary to severe pulmonary infection. This represents the first reported case of descending colon metastasis from primary ureteral UC. It highlights the colon as a potential metastatic site where biopsy is essential for definitive diagnosis. Notably, although the patient initially responded to platinum-based therapy, the subsequent rapid progression underscores the need for vigilant monitoring and timely adjustment of therapeutic strategies in managing such high-risk presentations.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13114641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-World Treatment Pathways of Adult Patients with Glioblastoma and Other CNS Tumors: A Population-Based Registry Study.","authors":"Eliana Ferroni, Alessandra Andreotti, Stefano Guzzinati, Susanna Baracco, Maddalena Baracco, Emanuela Bovo, Eva Carpin, Antonella Dal Cin, Alessandra Greco, Anna Rita Fiore, Laura Memo, Daniele Monetti, Silvia Rizzato, Jessica Elisabeth Stocco, Carmen Stocco, Sara Zamberlan, Marta Maccari, Alberto Bosio, Luca Denaro, Giampietro Pinna, Sara Lonardi, Giuseppe Lombardi, Manuel Zorzi","doi":"10.3390/curroncol33040236","DOIUrl":"https://doi.org/10.3390/curroncol33040236","url":null,"abstract":"<p><p><b>Background:</b> Population-level evidence on delivery of neuro-oncology care is essential for evaluating access, equity, and quality of treatment pathways. However, real-world data describing how patients with central nervous system (CNS) tumors, especially with glioblastoma, are managed across healthcare systems remain limited. This study aimed to characterize treatment pathways using linked registry and administrative data within a regional care network. <b>Methods:</b> All adult CNS tumors diagnosed between 2016 and 2020 were identified in the Veneto Cancer Registry. Tumor grading was derived using a validated text-mining algorithm, and surgical, radiotherapy, and systemic treatments were captured through linkage with regional healthcare utilization databases. Patterns of care were evaluated by tumor subtype, grade, and diagnostic pathway. <b>Results:</b> Among 1634 histologically confirmed tumors, glioblastoma represented the largest group. Surgical intervention was widely implemented, with high resection rates in glioblastoma and meningioma. Combined chemoradiotherapy constituted the primary adjuvant approach for glioblastoma and high-grade diffuse gliomas, whereas management of lower-grade tumors showed greater variability. Approximately one-third of patients received no oncologic therapy, primarily associated with older age or diagnostic uncertainty. Analysis of recurrent glioblastoma showed heterogeneous systemic treatment use, reflecting evolving therapeutic practice. <b>Conclusions:</b> Linking population-based registry and administrative data provides actionable insight into real-world delivery of neuro-oncology care, in particular for glioblastoma patients. This approach enables monitoring of treatment variability, identification of potential access gaps, and evaluation of system-level performance, supporting data-driven planning of multidisciplinary services and future quality improvement initiatives.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13114890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gender Differences in Palliative Care Experience and Quality Perceptions Among Cancer Patients in Saudi Arabia: Implications for Nursing Practice.","authors":"Muteb Aljuhani, Hanadi Dakhilallah, Rayhanah R Almutairi, Asrar S Almutairi, Waleed M Alshehri, Thurayya Eid, Abdulaziz M Alodhailah","doi":"10.3390/curroncol33040234","DOIUrl":"https://doi.org/10.3390/curroncol33040234","url":null,"abstract":"<p><p>Gender shapes healthcare experiences, yet its influence on palliative care (PC) in Middle Eastern contexts remains under-researched. Understanding how male and female patients differently experience PC is essential for delivering gender-sensitive nursing care. A cross-sectional study was conducted among 200 cancer patients recruited from healthcare facilities in Saudi Arabia. PC quality perceptions were measured using the Palliative Care Experience and Quality Questionnaire (PCEQQ), assessing communication, symptom management, emotional support, and overall quality. Independent-samples <i>t</i>-tests compared mean scores between male (<i>n</i> = 99) and female (<i>n</i> = 101) participants. Chi-square tests and logistic regression examined gender differences in access and associated factors. Female patients reported significantly higher overall satisfaction (M = 4.12 vs. M = 3.85, <i>p</i> = 0.008) and communication quality (M = 4.10 vs. M = 3.65, <i>p</i> = 0.002) compared to males. Females also demonstrated greater PC awareness (69.3% vs. 47.5%, <i>p</i> = 0.008) and access rates (64.4% vs. 47.5%, <i>p</i> = 0.013). Emotional support ratings approached significance, favoring females (<i>p</i> = 0.052), while symptom management showed no significant gender differences. These findings suggest that gender significantly shapes the PC experience in Saudi Arabia, with the most robust disparity appearing in provider, patient communication. Nurses should adopt gender-sensitive strategies to bridge the engagement gap for male patients, who may face cultural barriers to accessing supportive care.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13115389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Protective Role of Emotional Intelligence Against Occupational Burnout in Oncology Nursing: A Cross-Sectional Analysis in Saudi Arabian Hospitals.","authors":"Abdulaziz M Alodhailah, Bandar S Alharbi, Faihan F Alshaibany, Norah M Alyahya, Thurayya Eid, Albandari Almutairi","doi":"10.3390/curroncol33040233","DOIUrl":"https://doi.org/10.3390/curroncol33040233","url":null,"abstract":"<p><p>Oncology nursing is one of healthcare's most emotionally demanding specialties, characterized by sustained exposure to patient suffering and mortality. While global burnout rates reach 40-60%, emotional intelligence (EI) is a potential protective resource that remains underexamined in Middle Eastern contexts. Despite growing global evidence, little is known about these relationships in Middle Eastern healthcare systems, where cultural norms and workforce structures may shape emotional processes differently. This study examined whether EI was significantly associated with lower burnout across personal, work-related, and client-related dimensions among oncology nurses in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional correlational study enrolled 172 oncology nurses from three tertiary hospitals in Riyadh. Participants completed validated Arabic versions of the Schutte Self-Report Emotional Intelligence Test (SSEIT) and the Copenhagen Burnout Inventory (CBI). Hierarchical regression analyses examined predictive relationships while controlling for age and experience.</p><p><strong>Results: </strong>EI demonstrated significant inverse correlations with personal (r = -0.41), work-related (r = -0.38), and client-related burnout (r = -0.33, <i>p</i> < 0.001). In hierarchical models, EI emerged as a significant predictor of lower scores across all dimensions, explaining 11-17% of unique variance beyond demographic factors. The strongest association was with personal burnout. Causality cannot be inferred from this cross-sectional design.</p><p><strong>Conclusion: </strong>EI functions as a significant protective factor against burnout. Healthcare organizations should integrate EI development into professional training to strengthen workforce resilience and sustain care quality.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13115515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcome Measures to Assess the Effectiveness of Exercise Interventions on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Scoping Review.","authors":"Trei R Lindstrom, Joanna F Parkinson, Kerry S Courneya, Margaret L McNeely","doi":"10.3390/curroncol33040231","DOIUrl":"https://doi.org/10.3390/curroncol33040231","url":null,"abstract":"<p><p>Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of neurotoxic chemotherapy that can affect functioning and quality of life. Currently, duloxetine is the only recommended agent to treat painful CIPN; however, no effective pharmacological treatments have been approved for the prevention or cure of CIPN, highlighting the need to understand non-pharmacological strategies such as exercise. Given significant heterogeneity in the CIPN outcome measures chosen across studies, this scoping review aimed to identify the outcome measures used to evaluate the effectiveness of exercise interventions as a potential countermeasure for CIPN. Following the Arksey and O'Malley framework refined by Levac and colleagues, and the PRISMA-ScR guidelines, four databases were searched, and 20 studies were included in the review. Data were abstracted on study characteristics, cancer and chemotherapy factors, exercise prescription, outcome measures, and CIPN-related findings. Outcome measures varied widely across studies, encompassing various patient-reported, clinical, and functional measures. The most common patient-reported, clinical, and functional measures were the EORTC QLQ-CIPN20, vibration sensation, and maximal isometric strength, respectively. No study satisfied the components of the core outcome measure set proposed by Park and colleagues, limiting cross-study comparisons. These findings underscore the need for standardized CIPN outcome measures in future exercise studies to strengthen evidence synthesis and inform clinical practice.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13114490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Mediating Role of Team Resilience at Work Between Teamwork Practice Environment, Team Functioning and Cohesion in Oncology: A Cross-Sectional Study.","authors":"Dominique Tremblay, Djamal Berbiche, Susan Usher, Marie-José Durand, Kelley Kilpatrick, Marjolaine Landry, Sylvie Lessard, Thomas G Poder, Catherine Prady, Mathieu Roy, Nassera Touati, Annie Turcotte","doi":"10.3390/curroncol33040232","DOIUrl":"https://doi.org/10.3390/curroncol33040232","url":null,"abstract":"<p><p>Oncology teams operate in highly demanding clinical environments marked by recurrent acute and chronic stressors that can impair optimal quality of care. Although the practice environment is known to influence team processes, the specific contribution of team resilience at work to team effectiveness remains insufficiently delineated in oncology. This cross-sectional study investigated whether team resilience at work mediates the associations between the teamwork practice environment and two core indicators of team effectiveness: team functioning and team cohesion. A total of 189 oncology team members in Québec (Canada) completed an e-questionnaire between February 2022 and June 2023. Structural equation modeling was conducted to assess an evidence-informed mediation model. The tested model revealed acceptable fit. Findings showed significant indirect effects consistent with a mediating role of team resilience at work in the relationships between the teamwork practice environment and team functioning and team cohesion. Some dimensions-resourcefulness, alignment, efforts to understand problems, wellness awareness and being proud to work in the team-loaded strongly on the resilience concept. These results highlight the relevance of reinforcing team resilience capacities to sustain high-quality care in oncology settings. Interventions aiming to enhance team effectiveness may benefit from explicitly integrating strategies designed to strengthen resilience-related dimensions within oncology teams.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13115152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors.","authors":"Harsh A Patel, Saifullah Syed, Pranathi Tella, Harshith Thyagaturu, Brijesh Patel","doi":"10.3390/curroncol33040230","DOIUrl":"https://doi.org/10.3390/curroncol33040230","url":null,"abstract":"<p><p><b>Introduction:</b> Cardiovascular disease (CVD) is a leading cause of non-cancer death among cancer survivors, attributable to cardiotoxic therapies and cardiovascular risk factors. General population risk prediction tools, including ASCVD (Atherosclerotic cardiovascular disease), Framingham's Score, and PREVENT (Predicting Risk of Cardiovascular Disease EVENTS), lack cancer-specific variables. We evaluated whether these models, even after statistical optimization, could predict cardiovascular mortality in cancer survivors. <b>Methods:</b> Using the National Health and Nutrition Examination Survey (NHANES) 2001-2018, linked with National Death Index (NDI) mortality data, we conducted a retrospective analysis of 634 and 429 cancer survivors, respectively, across model-specific cohorts free of baseline cardiovascular disease. Discrimination was assessed for ASCVD, Framingham Score, and PREVENT using standardized thresholds of 7.5% and 20%, as well as Youden-optimized cutoffs. Area under the curve (AUC) comparisons were performed using the DeLong non-parametric method. <b>Results:</b> Standard thresholds showed suboptimal discrimination across all models (AUCs: ASCVD 0.56, Framingham 0.53, PREVENT 0.64). In contrast, Youden-optimized AUCs (ASCVD: 0.68; PREVENT: 0.71; all <i>p</i> < 0.001, DeLong test). Optimization increased the \"low-risk\" group's mortality rate from 2.8% to 4.1% (RR = 1.47), suggesting improved statistical fit came at the cost of overestimating the risk. Optimized thresholds outperformed conventional cutoffs, underscoring the necessity for recalibrated, cohort-specific risk stratification in cancer survivors. <b>Conclusions:</b> Standard risk scores have inadequate discrimination for cardiovascular mortality prediction in cancer survivors. Threshold recalibration improves statistical metrics but does not resolve the structural failure of these models to account for cardiotoxic exposure. Development of cardio-oncology-specific risk models incorporating oncologic exposures is therefore warranted.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13115454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Breaking Bad News: The Perspective and Experience of Women with Gynecological Cancer (Results of the NOGGO-Expression XX Survey).","authors":"Ela Igde, Gülten Oskay-Özcelik, Jekaterina Vasiljeva, Murat Karaman, Susanne Fechner, Adak Pirmorady Sehouli, Jalid Sehouli","doi":"10.3390/curroncol33040229","DOIUrl":"https://doi.org/10.3390/curroncol33040229","url":null,"abstract":"<p><p><b>Background:</b> Effective communication improves patient satisfaction and reduces stress for both patients and physicians. Surveys consistently highlight the importance of strong communication skills among physicians, especially in oncologic settings. Yet, communication training is neither ubiquitous nor standardized in medical studies or residency, and physicians report that this task represents a burden for them. Given the limited data addressing the observations and expectations of patients with gynecologic malignancies when receiving bad news, this survey aimed to assess their perspective on this topic. <b>Methods:</b> We examined throughout an anonymous questionnaire how patients with gynecological and breast cancer experienced the delivery of bad news. Data were collected in Germany from July 2024 to September 2025. The questionnaire was available online and in paper form in four languages (German, English, Turkish, Arabic), with the purpose of recording culture-specific data. <b>Results:</b> A total of 249 patients completed the survey. Regarding the overall need for improvement in delivering bad news, 222 women (94.5%) declared that improvement was necessary, with 92 (39.1%) of them indicating that substantial improvement was required. While 67.9% of patients were content with the physician's professional competence, 30.5% stated a lack of empathy, and 32.9% stated insufficient time for conversation. When comparing satisfied and dissatisfied patients, significant differences were observed across several aspects, such as consultation length, nonverbal communication, calmness of the setting, stress level after the conversation, and the offer to bring a trusted person or arrange a follow-up conversation. <b>Conclusions:</b> This patient survey highlights a persistent gap between patients' expectations and physicians' performance when it comes to delivering bad news. The findings underline the urgent need for the implementation of systematic training programs and structured communication protocols in gynecologic oncology.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13114406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reconsidering the Interpretation of \"Recurrence-Free Survival\" After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. <i>Curr. Oncol.</i> 2026, <i>33</i>, 89.","authors":"Janhavi Venkataraman, Kefah Mokbel","doi":"10.3390/curroncol33040223","DOIUrl":"https://doi.org/10.3390/curroncol33040223","url":null,"abstract":"<p><p>Sae-sim et al [...].</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13115277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.","authors":"Arwa Ahmed, Stéphanie L Mercier, Ravi Ramjeesingh, Robert Thompson, Donald James Bastin, Silvana Spadafora, Thais Baccili Cury Megid, Vladimir Djedovic, Amandeep S Taggar, Conrad Falkson, Abdul Rehman Farooq, Gordon Emil Locke, Stacie Connors, Hao Yu Wang, Mustapha Tehfe, Francine Aubin, Setareh Samimi, James Michael, Holly Campbell, Eve St-Hilaire, Suneil Khanna, Mohammed Saud Ali Al Darai, Pierre Whitlock, Angela Hyde, Luisa Galvis, Marie-Philippe Saltiel, Adrian Bailey, Doha Itani, Rakesh Goel, Wadima Aldarmaki, Shivani Dadwal, Rachel Goodwin, Timothy R Asmis","doi":"10.3390/curroncol33040228","DOIUrl":"https://doi.org/10.3390/curroncol33040228","url":null,"abstract":"<p><p>The Eastern Canadian Gastrointestinal Cancer Consensus Conference convened annually and was held in Fredericton, New Brunswick, from 18 to 20 September 2025. Attendees included experts in medical oncology, radiation oncology, nuclear medicine, and general practitioners in oncology (GPO) from across the eastern Canadian provinces who are engaged in the care and management of patients with gastrointestinal malignancies. The consensus statement resulting from this meeting addresses several key topics, including the management of early-stage gastroesophageal junction cancer, recent developments in molecular biomarkers and colorectal cancer treatments, secondary prevention strategies for colorectal cancer, and treatment of hepatocellular carcinoma.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"33 4","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13114314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147765200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}